Singapore: Even as big and emerging names continue to tie up with Korea's biggest international health convention, the e...
Singapore: INC Research, a therapeutically focused clinical research organization (CRO) with a trusted process for deli...
Established in 1978, Taejoon Pharm has been a leading specialty pharma company in Korea in ophthalmology, contrast media...
Singapore: Medical device developer, Covidien, has launched Covidien Center of Innovation Korea (CCI Korea), its first R...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: Israel-based ARGO Medical Technologies has partnered with innovative robotics experts Yaskawa Electric, Japan...
Singapore: Korean Food and Drug Administration (KFDA) has accepted Hanmi Pharmaceutical's investigational new drug appl...
Singapore: Medgenics received a Notice of Allowance from the Japanese Patent and Trademark Office for key claims protec...
In South Korea, two research teams led by Prof. Park Se-pill at Jeju National University Stem Cell Research Center and M...
Singapore: NeuroMetrix and Handok Pharmaceuticals entered into an agreement according to which, Handok will be the exclu...
Singapore: South Korea's leading pharmaceutical company, Daewoong Pharma has signed a deal to take over Liaoning Baifeng...
Singapore: Varian Medical Systems, the world leader in radiotherapy and radiosurgery, is strengthening its leadership po...
Singapore: Kinex Pharmaceuticals and Hanmi Pharmaceutical announced today that the first patient has been enrolled in Ha...
Singapore: Canada-based Quest PharmaTech, a pharmaceutical company developing and commercializing products for the trea...
Singapore: Samsung Electronics America, a subsidiary of South Korean company Samsung Electronics, has acquired NeuroLogi...
Singapore: Eisai's South Korean sales subsidiary has received approval from the regulatory authorities in South Korea to...
Korea-based LegoChem Biosciences (LCB) was started in 2006 with the objective to accelerate discovery and development of...
Singapore: Sweden-based Medivir has discontinued the development of its hepatitis B compound MIV-210 based on a joint de...
